Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Paulson, K.G., Thompson, J.A.","A second chance for success with BRAF and MEK inhibitors in melanoma",2017,"The Lancet Oncology","18","4",,"418","419",,,10.1016/S1470-2045(17)30151-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014177510&doi=10.1016%2fS1470-2045%2817%2930151-1&partnerID=40&md5=9ae166f220c7a0e36e8cb6d4bff773ee",Note,Scopus,2-s2.0-85014177510
"Frankel, A.E., Flaherty, K.T., Weiner, G.J., Chen, R., Azad, N.S., Pishvaian, M.J., Thompson, J.A., Taylor, M.H., Mahadevan, D., Lockhart, A.C., Vaishampayan, U.N., Berlin, J.D., Smith, D.C., Sarantopoulos, J., Riese, M., Saleh, M.N., Ahn, C., Frenkel, E.P.","Academic cancer center phase i program development",2017,"Oncologist","22","4",,"369","374",,,10.1634/theoncologist.2016-0409,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017435066&doi=10.1634%2ftheoncologist.2016-0409&partnerID=40&md5=f38702aaca228054a86dfe23e47b3676",Note,Scopus,2-s2.0-85017435066
"Long, G.V., Atkinson, V., Cebon, J.S., Jameson, M.B., Fitzharris, B.M., McNeil, C.M., Hill, A.G., Ribas, A., Atkins, M.B., Thompson, J.A., Hwu, W.-J., Hodi, F.S., Menzies, A.M., Guminski, A.D., Kefford, R., Kong, B.Y., Tamjid, B., Srivastava, A., Lomax, A.J., Islam, M., Shu, X., Ebbinghaus, S., Ibrahim, N., Carlino, M.S.","Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): An open-label, phase 1b trial",2017,"The Lancet Oncology",,,,"","",,,10.1016/S1470-2045(17)30428-X,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024497892&doi=10.1016%2fS1470-2045%2817%2930428-X&partnerID=40&md5=cbbfbadcb2aca07ddc09fd0adb412dc5",Article in Press,Scopus,2-s2.0-85024497892
"Chapuis, A.G., Roberts, I.M., Thompson, J.A., Margolin, K.A., Bhatia, S., Lee, S.M., Sloan, H.L., Lai, I.P., Farrar, E.A., Wagener, F., Shibuya, K.C., Cao, J., Wolchok, J.D., Greenberg, P.D., Yee, C.","T-cell therapy using interleukin-21-primed cytotoxic T-cell lymphocytes combined with cytotoxic T-cell lymphocyte antigen-4 blockade results in long-term cell persistence and durable tumor regression",2016,"Journal of Clinical Oncology","34","31",,"3787","3795",,7,10.1200/JCO.2015.65.5142,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84993985148&doi=10.1200%2fJCO.2015.65.5142&partnerID=40&md5=bd54a173d9f229e41701278358660689",Article,Scopus,2-s2.0-84993985148
"Bono, P., Oudard, S., Bodrogi, I., Hutson, T.E., Escudier, B., Machiels, J.-P., Thompson, J.A., Figlin, R.A., Ravaud, A., Basaran, M., Porta, C., Bracarda, S., Brechenmacher, T., Lin, C., Voi, M., Grunwald, V., Motzer, R.J.","Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials",2016,"Clinical Genitourinary Cancer","14","5",,"406","414",,2,10.1016/j.clgc.2016.04.011,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973582514&doi=10.1016%2fj.clgc.2016.04.011&partnerID=40&md5=ce60cdb8e30163a180603750d1008928",Article,Scopus,2-s2.0-84973582514
"Bhatia, S., Pavlick, A.C., Boasberg, P., Thompson, J.A., Mulligan, G., Pickard, M.D., Faessel, H., Dezube, B.J., Hamid, O.","A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma",2016,"Investigational New Drugs","34","4",,"439","449",,3,10.1007/s10637-016-0348-5,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964033552&doi=10.1007%2fs10637-016-0348-5&partnerID=40&md5=f90d9071f9b9263e71d89de579388d0c",Article,Scopus,2-s2.0-84964033552
"Thompson, J.A.","Major changes in systemic therapy for advanced melanoma",2016,"JNCCN Journal of the National Comprehensive Cancer Network","14",,,"638","640",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995802690&partnerID=40&md5=df77f1e3e6ccbee405badd8083ea6c5a",Conference Paper,Scopus,2-s2.0-84995802690
"Bhatia, S., Thompson, J.A.","PD-1 blockade in melanoma: A promising start, but a long way to go",2016,"JAMA - Journal of the American Medical Association","315","15",,"1573","1575",,4,10.1001/jama.2016.4012,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964329584&doi=10.1001%2fjama.2016.4012&partnerID=40&md5=5e5dff1020a7e0ae1d74df9a5419f0ed",Editorial,Scopus,2-s2.0-84964329584
"Olszanski, A.J., Smith, D.C., Camacho, L.H., Thompson, J., Ramalingam, S.S., Donald Harvey, R., Campos, L., Ferry, D., Tang, S., Gao, L., Safran, H.","Electrocardiographic characterization of ramucirumab on the corrected qt interval in a phase ii study of patients with advanced solid tumors",2016,"Oncologist","21","4",,"402","403",,,10.1634/theoncologist.2015-0467,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963813192&doi=10.1634%2ftheoncologist.2015-0467&partnerID=40&md5=a08d11aa4454fabe558666e260ff3bfb",Article,Scopus,2-s2.0-84963813192
"Coit, D.G., Thompson, J.A., Algazi, A., Andtbacka, R., Bichakjian, C.K., Carson, W.E., Daniels, G.A., DiMaio, D., Ernstoff, M., Fields, R.C., Fleming, M.D., Gonzalez, R., Guild, V., Halpern, A.C., Hodi, F.S., Joseph, R.W., Lange, J.R., Martini, M.C., Materin, M.A., Olszanski, A.J., Ross, M.I., Salama, A.K., Skitzki, J., Sosman, J., Swetter, S.M., Tanabe, K.K., Torres-Roca, J.F., Trisal, V., Urist, M.M., McMillian, N., Engh, A.","Melanoma, version 2.2016 clinical practice guidelines in oncology",2016,"JNCCN Journal of the National Comprehensive Cancer Network","14","4",,"450","473",,20,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964355523&partnerID=40&md5=4916f1bb4e32f94cf0591c41b254dd27",Article,Scopus,2-s2.0-84964355523
"Chapuis, A.G., Lee, S.M., Thompson, J.A., Roberts, I.M., Margolin, K.A., Bhatia, S., Sloan, H.L., Lai, I., Wagener, F., Shibuya, K., Cao, J., Wolchok, J.D., Greenberg, P.D., Yee, C.","Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient",2016,"Journal of Experimental Medicine","213","7",,"1133","1139",,7,10.1084/jem.20152021,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977626639&doi=10.1084%2fjem.20152021&partnerID=40&md5=c325ab67226462237f0464498207ba4a",Article,Scopus,2-s2.0-84977626639
"Smith, D.C., Kalebic, T., Infante, J.R., Siu, L.L., Sullivan, D., Vlahovic, G., Kauh, J.S., Gao, F., Berger, A.J., Tirrell, S., Gupta, N., Di Bacco, A., Berg, D., Liu, G., Lin, J., Hui, A.-M., Thompson, J.A.","Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies",2015,"Investigational New Drugs","33","3",,"652","663",,11,10.1007/s10637-015-0230-x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939984782&doi=10.1007%2fs10637-015-0230-x&partnerID=40&md5=cb2960d7f15d8cd7b0a8b0b82637a48d",Article,Scopus,2-s2.0-84939984782
"Thompson, J.A.","Treatment options expanding for advanced melanoma",2015,"JNCCN Journal of the National Comprehensive Cancer Network","13",,,"673","675",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84996528887&partnerID=40&md5=b85e3aa6c49af2092ad72f72f08924ae",Conference Paper,Scopus,2-s2.0-84996528887
"Bhatia, S., Tykodi, S.S., Lee, S.M., Thompson, J.A.","Systemic therapy of metastatic melanoma: on the road to cure",2015,"Oncology (Williston Park, N.Y.)","29","2",,"126","135",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922727813&partnerID=40&md5=1e5215df36fa3be4bb2ba92087b120d7",Review,Scopus,2-s2.0-84922727813
"Bhatia, S., Tykodi, S.S., Lee, S.M., Thompson, J.A.","Systemic therapy of metastatic melanoma: On the road to cure",2015,"ONCOLOGY (United States)","29","2",,"","",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922732806&partnerID=40&md5=e1ce58c15210bb149097ff4d2fc1de1a",Review,Scopus,2-s2.0-84922732806
"Tannir, N.M., Forero-Torres, A., Ramchandren, R., Pal, S.K., Ansell, S.M., Infante, J.R., De Vos, S., Hamlin, P.A., Kim, S.K., Whiting, N.C., Gartner, E.M., Zhao, B., Thompson, J.A.","Phase i dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma",2014,"Investigational New Drugs","32","6",,"1246","1257",,7,10.1007/s10637-014-0151-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927557126&doi=10.1007%2fs10637-014-0151-0&partnerID=40&md5=5e5bf420875b698309deea017ec0cfb1",Article,Scopus,2-s2.0-84927557126
"Flaherty, L.E., Othus, M., Atkins, M.B., Tuthill, R.J., Thompson, J.A., Vetto, J.T., Haluska, F.G., Pappo, A.S., Sosman, J.A., Redman, B.G., Moon, J., Ribas, A., Kirkwood, J.M., Sondak, V.K.","Southwest oncology group S0008: A Phase III trial of high-dose interferon alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma-an intergroup study of cancer and leukemia group B, children's oncology group, eastern cooperative oncology group, and southwest oncology group",2014,"Journal of Clinical Oncology","32","33",,"3771","3778",,21,10.1200/JCO.2013.53.1590,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911411511&doi=10.1200%2fJCO.2013.53.1590&partnerID=40&md5=6827265a274c6d34d31dabece0737ff4",Article,Scopus,2-s2.0-84911411511
"Ravi, S., Spencer, K., Ruisi, M., Ibrahim, N., Luke, J.J., Thompson, J.A., Shirai, K., Lawson, D., Bartell, H., Kudchadkar, R., Gunter, N.T., Mehnert, J.M., Lipson, E.J.","Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: A multicenter, retrospective case series",2014,"Journal for ImmunoTherapy of Cancer","2","1", 33,"","",,5,10.1186/s40425-014-0033-1,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977090790&doi=10.1186%2fs40425-014-0033-1&partnerID=40&md5=e93f8600121bf68ff649cc70ba112fb1",Article,Scopus,2-s2.0-84977090790
"Carson, W.E., Unger, J.M., Sosman, J.A., Flaherty, L.E., Tuthill, R.J., Porter, M.J., Thompson, J.A., Kempf, R.A., Othus, M., Ribas, A., Sondak, V.K.","Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival",2014,"Cancer immunology research","2","10",,"981","987",,1,10.1158/2326-6066.CIR-14-0052,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85003050549&doi=10.1158%2f2326-6066.CIR-14-0052&partnerID=40&md5=249053d2c557ef91487de9ca4a6f2dda",Article,Scopus,2-s2.0-85003050549
"Tannir, N.M., Forero-Torres, A., Ramchandren, R., Pal, S.K., Ansell, S.M., Infante, J.R., de Vos, S., Hamlin, P.A., Kim, S.K., Whiting, N.C., Gartner, E.M., Zhao, B., Thompson, J.A.","Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma",2014,"Investigational New Drugs",,,,"","",,13,10.1007/s10637-014-0151-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906029633&doi=10.1007%2fs10637-014-0151-0&partnerID=40&md5=556229cbe7ecc7955e48af50425d8612",Article in Press,Scopus,2-s2.0-84906029633
"Garcia, J.A., Hudes, G.R., Choueiri, T.K., Stadler, W.M., Wood, L.S., Gurtler, J., Bhatia, S., Joshi, A., Hozak, R.R., Xu, Y., Schwartz, J.D., Thompson, J.A.","A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy",2014,"Cancer","120","11",,"1647","1655",,20,10.1002/cncr.28634,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901301933&doi=10.1002%2fcncr.28634&partnerID=40&md5=ccb0772b5b3b2c432430f8bf83a276a1",Conference Paper,Scopus,2-s2.0-84901301933
"Thompson, J.A.","Agents make ""preferred list"" in metastatic melanoma",2014,"JNCCN Journal of the National Comprehensive Cancer Network","12","5 SUPPL.",,"785","787",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902496138&partnerID=40&md5=bcb79f86d7e6532f473941707f234b6a",Conference Paper,Scopus,2-s2.0-84902496138
"Bhatia, S., Curti, B., Ernstoff, M.S., Gordon, M., Heath, E.I., Miller, W.H., Puzanov, I., Quinn, D.I., Flaig, T.W., VanVeldhuizen, P., Byrnes-Blake, K., Freeman, J.A., Bittner, R., Hunder, N., Souza, S., Thompson, J.A.","Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: A phase 1/2 study",2014,"Journal for ImmunoTherapy of Cancer","2","1", 2,"","",,5,10.1186/2051-1426-2-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977111822&doi=10.1186%2f2051-1426-2-2&partnerID=40&md5=adf651ba8bb445004090130baf96ebac",Article,Scopus,2-s2.0-84977111822
"Bhatia, S., Thompson, J.A.","Melanoma: Immune checkpoint blockade story gets better",2014,"The Lancet","384","9948",,"1078","1079",,5,10.1016/S0140-6736(14)61140-5,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908327768&doi=10.1016%2fS0140-6736%2814%2961140-5&partnerID=40&md5=7476029c2ba0c5a0389b440be3e694cc",Note,Scopus,2-s2.0-84908327768
"Liao, J.J., Parvathaneni, U., Laramore, G.E., Thompson, J.A., Bhatia, S., Futran, N.D., Bhrany, A.D., Hawes, S.E., Ladra, M.","Fast neutron radiotherapy for primary mucosal melanomas of the head and neck",2014,"Head and Neck","36","8",,"1162","1167",,7,10.1002/hed.23428,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904259115&doi=10.1002%2fhed.23428&partnerID=40&md5=1db142dc9a76c80cb1199d8622d17ce0",Article,Scopus,2-s2.0-84904259115
"Carvajal, R.D., Wong, M.K., Thompson, J.A., Gordon, M.S., Lewis, K.D., Pavlick, A.C., Wolchok, J.D., Rojas, P.B., Schwartz, J.D., Bedikian, A.Y.","A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma",2014,"European Journal of Cancer","50","12",,"2099","2107",,8,10.1016/j.ejca.2014.03.289,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904049824&doi=10.1016%2fj.ejca.2014.03.289&partnerID=40&md5=b14ece0a5fb4b375ed7511170cacd761",Article,Scopus,2-s2.0-84904049824
"McDermott, D., Lebbé, C., Hodi, F.S., Maio, M., Weber, J.S., Wolchok, J.D., Thompson, J.A., Balch, C.M.","Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma",2014,"Cancer Treatment Reviews","40","9",,"1056","1064",,74,10.1016/j.ctrv.2014.06.012,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926648478&doi=10.1016%2fj.ctrv.2014.06.012&partnerID=40&md5=ce8f5bc435e0e702efd3efe130b2cecf",Review,Scopus,2-s2.0-84926648478
"Coit, D.G., Thompson, J.A., Andtbacka, R., Anker, C.J., Bichakjian, C.K., Carson III, W.E., Daniels, G.A., Daud, A., DiMaio, D., Fleming, M.D., Gonzalez, R., Guild, V., Halpern, A.C., Hodi Jr., F.S., Kelley, M.C., Khushalani, N.I., Kudchadkar, R.R., Lange, J.R., Martini, M.C., Olszanski, A.J., Ross, M.I., Salama, A., Swetter, S.M., Tanabe, K.K., Trisal, V., Urist, M.M., McMillian, N.R., Ho, M.","Melanoma, version 4.2014: Featured updates to the NCCN guidelines",2014,"JNCCN Journal of the National Comprehensive Cancer Network","12","5",,"621","629",,38,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900423555&partnerID=40&md5=b8f60f9e525b395fea6e82e2f9bcddcd",Review,Scopus,2-s2.0-84900423555
"Kaufman, H.L., Kirkwood, J.M., Hodi, F.S., Agarwala, S., Amatruda, T., Bines, S.D., Clark, J.I., Curti, B., Ernstoff, M.S., Gajewski, T., Gonzalez, R., Hyde, L.J., Lawson, D., Lotze, M., Lutzky, J., Margolin, K., McDermott, D.F., Morton, D., Pavlick, A., Richards, J.M., Sharfman, W., Sondak, V.K., Sosman, J., Steel, S., Tarhini, A., Thompson, J.A., Titze, J., Urba, W., White, R., Atkins, M.B.","The society for immunotherapy of cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma",2013,"Nature Reviews Clinical Oncology","10","10",,"588","598",,78,10.1038/nrclinonc.2013.153,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885022736&doi=10.1038%2fnrclinonc.2013.153&partnerID=40&md5=0e30c9d26e9248b2d92cb6e07458b32e",Review,Scopus,2-s2.0-84885022736
"Thompson, J.A.","New prescribing options in metastatic melanoma",2013,"American Journal of Pharmacy Benefits","5","5",,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888159636&partnerID=40&md5=89ace0770b274c4bf777a1d2bb2ef374",Article,Scopus,2-s2.0-84888159636
"Sharma, A., Thompson, J.A., Repaka, A., Mehnert, J.M.","Ipilimumab administration in patients with advanced melanoma and hepatitis B and C",2013,"Journal of Clinical Oncology","31","21",,"e370","e371",,8,10.1200/JCO.2012.47.1946,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890478215&doi=10.1200%2fJCO.2012.47.1946&partnerID=40&md5=e9860fd683645dcd72b216795c138df0",Article,Scopus,2-s2.0-84890478215
"Coit, D.G., Andtbacka, R., Anker, C.J., Bichakjian, C.K., Carson, W.E., Daud, A., DiMaio, D., Fleming, M.D., Guild, V., Halpern, A.C., Hodi Jr., F.S., Kelley, M.C., Khushalani, N.I., Kudchadkar, R.R., Lange, J.R., Lind, A., Martini, M.C., Olszanski, A.J., Pruitt, S.K., Ross, M.I., Swetter, S.M., Tanabe, K.K., Thompson, J.A., Trisal, V., Urist, M.M., McMillian, N., Ho, M.","Melanoma, version 2.2013: Featured updates to the NCCN guidelines",2013,"JNCCN Journal of the National Comprehensive Cancer Network","11","4",,"395","407",,74,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877996512&partnerID=40&md5=4e8b243cf59e5c3c37c167893d135c54",Article,Scopus,2-s2.0-84877996512
"Thompson, J.A.","Ten years of progress in melanoma",2012,"JNCCN Journal of the National Comprehensive Cancer Network","10","8",,"932","935",,2,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865315390&partnerID=40&md5=e15a8f643ec1311d7ef06d5c250f690e",Note,Scopus,2-s2.0-84865315390
"Motzer, R.J., Hutson, T.E., Olsen, M.R., Hudes, G.R., Burke, J.M., Edenfield, W.J., Wilding, G., Agarwal, N., Thompson, J.A., Cella, D., Bello, A., Korytowsky, B., Yuan, J., Valota, O., Martell, B., Hariharan, S., Figlin, R.A.","Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma",2012,"Journal of Clinical Oncology","30","12",,"1371","1377",,147,10.1200/JCO.2011.36.4133,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860355062&doi=10.1200%2fJCO.2011.36.4133&partnerID=40&md5=b216156286de1903736bdc8748bd6884",Article,Scopus,2-s2.0-84860355062
"Chapuis, A.G., Thompson, J.A., Margolin, K.A., Rodmyre, R., Lai, I.P., Dowdy, K., Farrar, E.A., Bhatia, S., Sabath, D.E., Cao, J., Li, Y., Yee, C.","Transferred melanoma-specific CD8 + T cells persist, mediate tumor regression, and acquire central memory phenotype",2012,"Proceedings of the National Academy of Sciences of the United States of America","109","12",,"4592","4597",,67,10.1073/pnas.1113748109,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863337726&doi=10.1073%2fpnas.1113748109&partnerID=40&md5=65755964474b99874faeb0a1db9d21b3",Article,Scopus,2-s2.0-84863337726
"Bhatia, S., Thompson, J.A.","Systemic therapy for metastatic melanoma in 2012: Dawn of a new era",2012,"JNCCN Journal of the National Comprehensive Cancer Network","10","3",,"403","412",,20,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863401647&partnerID=40&md5=17db6fa6b67aa0b7b7023dde8d334384",Review,Scopus,2-s2.0-84863401647
"Coit, D.G., Andtbacka, R., Anker, C.J., Bichakjian, C.K., Carson III, W.E., Daud, A., Dilawari, R.A., DiMaio, D., Guild, V., Halpern, A.C., Hodi Jr., F.S., Kelley, M.C., Khushalani, N.I., Kudchadkar, R.R., Lange, J.R., Lind, A., Martini, M.C., Olszanski, A.J., Pruitt, S.K., Ross, M.I., Swetter, S.M., Tanabe, K.K., Thompson, J.A., Trisal, V., Urist, M.M.","Melanoma",2012,"JNCCN Journal of the National Comprehensive Cancer Network","10","3",,"366","400",,43,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863393453&partnerID=40&md5=2637fd196918ca58c8cb2fae4835d7de",Review,Scopus,2-s2.0-84863393453
"Calvo, E., Escudier, B., Motzer, R.J., Oudard, S., Hutson, T.E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J.A., Ravaud, A., Kim, D., Panneerselvam, A., Anak, O., Figlin, R.A.","Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study",2012,"European Journal of Cancer","48","3",,"333","339",,76,10.1016/j.ejca.2011.11.027,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856211584&doi=10.1016%2fj.ejca.2011.11.027&partnerID=40&md5=4f085b2e71379070459ecd9dad64bc70",Article,Scopus,2-s2.0-84856211584
"Bhatia, S., Thompson, J.A.","Novel cytokines for immunotherapy of melanoma",2012,"Targeted Therapeutics in Melanoma",,,,"333","351",,,10.1007/978-1-61779-407-0_17,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026226049&doi=10.1007%2f978-1-61779-407-0_17&partnerID=40&md5=670f63fe3c680794969c54cbd6cf2c06",Book Chapter,Scopus,2-s2.0-85026226049
"Thompson, J.A., Hamid, O., Minor, D., Amin, A., Ron, I.G., Ridolfi, R., Assi, H., Berman, D., Siegel, J., Weber, J.S.","Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: Retrospective analysis of efficacy and safety data from a phase II trial",2012,"Journal of Immunotherapy","35","1",,"73","77",,20,10.1097/CJI.0b013e31823735d6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84155163012&doi=10.1097%2fCJI.0b013e31823735d6&partnerID=40&md5=6cf5b9e67b85fa39e549a8f84b3174a0",Article,Scopus,2-s2.0-84155163012
"Fishman, M.N., Thompson, J.A., Pennock, G.K., Gonzalez, R., Diez, L.M., Daud, A.I., Weber, J.S., Huang, B.Y., Tang, S., Rhode, P.R., Wong, H.C.","Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies",2011,"Clinical Cancer Research","17","24",,"7765","7775",,25,10.1158/1078-0432.CCR-11-1817,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84055212017&doi=10.1158%2f1078-0432.CCR-11-1817&partnerID=40&md5=5dc344797f43526c4e29f637f82ffe74",Article,Scopus,2-s2.0-84055212017
"O'Day, S., Pavlick, A., Loquai, C., Lawson, D., Gutzmer, R., Richards, J., Schadendorf, D., Thompson, J.A., Gonzalez, R., Trefzer, U., Mohr, P., Chao, D., Zhong, B., De Boer, C.J., Uhlar, C., Marshall, D., Gore, M.E., Lang, Z., Hait, W., Ho, P.","A randomised, phase II study of intetumumab, an anti-α v-integrin mAb, alone and with dacarbazine in stage IV melanoma",2011,"British Journal of Cancer","105","3",,"346","352",,50,10.1038/bjc.2011.183,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960844245&doi=10.1038%2fbjc.2011.183&partnerID=40&md5=989beea2ecdda773bb4104d8ef97d4dc",Article,Scopus,2-s2.0-79960844245
"Patel, P.M., Suciu, S., Mortier, L., Kruit, W.H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C.J.A., Dummer, R., Davidson, N., Becker, J., Conry, R., Thompson, J.A., Hwu, W.-J., Engelen, K., Agarwala, S.S., Keilholz, U., Eggermont, A.M.M., Spatz, A.","Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)",2011,"European Journal of Cancer","47","10",,"1476","1483",,107,10.1016/j.ejca.2011.04.030,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79958783120&doi=10.1016%2fj.ejca.2011.04.030&partnerID=40&md5=df52b7281e3edd39e4cb0c83f522d4d1",Article,Scopus,2-s2.0-79958783120
"Tykodi, S.S., Sandmaier, B.M., Warren, E.H., Thompson, J.A.","Allogeneic hematopoietic cell transplantation for renal cell carcinoma: Ten years after",2011,"Expert Opinion on Biological Therapy","11","6",,"763","773",,7,10.1517/14712598.2011.566855,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955791376&doi=10.1517%2f14712598.2011.566855&partnerID=40&md5=7dd2e945de5a2aa24cb9ffaa6fcd2fb3",Review,Scopus,2-s2.0-79955791376
"Amato, R.J., Hawkins, R.E., Kaufman, H.L., Thompson, J.A., Tomczak, P., Szczylik, C., McDonald, M., Eastty, S., Shingler, W.H., De Belin, J., Goonewardena, M., Naylor, S., Harrop, R.","Vaccination of metastatic renal cancer patients with MVA-5T4: A randomized, double-blind, placebo-controlled phase III study",2010,"Clinical Cancer Research","16","22",,"5539","5547",,104,10.1158/1078-0432.CCR-10-2082,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-78349284842&doi=10.1158%2f1078-0432.CCR-10-2082&partnerID=40&md5=3a4ed730c007540c3755866a70bb4147",Article,Scopus,2-s2.0-78349284842
"Samlowski, W.E., Moon, J., Tuthill, R.J., Heinrich, M.C., Balzer-Haas, N.S., Merl, S.A., DeConti, R.C., Thompson, J.A., Witter, M.T., Flaherty, L.E., Sondak, V.K.","A phase II trial of imatinib mesylate in merkel cell carcinoma (Neuroendocrine carcinoma of the skin): A Southwest oncology group study (S0331)",2010,"American Journal of Clinical Oncology: Cancer Clinical Trials","33","5",,"495","499",,39,10.1097/COC.0b013e3181b9cf04,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-78049433610&doi=10.1097%2fCOC.0b013e3181b9cf04&partnerID=40&md5=b05ad16b3b006db7a7066d4be4e7ddee",Article,Scopus,2-s2.0-78049433610
"Motzer, R.J., Escudier, B., Oudard, S., Hutson, T.E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J.A., Figlin, R.A., Hollaender, N., Kay, A., Ravaud, A.","Phase 3 trial of everolimus for metastatic renal cell carcinoma: Final results and analysis of prognostic factors",2010,"Cancer","116","18",,"4256","4265",,755,10.1002/cncr.25219,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956227464&doi=10.1002%2fcncr.25219&partnerID=40&md5=53bdb1d6dca5588e52345e48fcb6f27d",Article,Scopus,2-s2.0-77956227464
"Lord, J.D., Hackman, R.C., Moklebust, A., Thompson, J.A., Higano, C.S., Chielens, D., Steinbach, G., McDonald, G.B.","Refractory colitis following anti-CTLA4 antibody therapy: Analysis of mucosal FOXP3+ T cells",2010,"Digestive Diseases and Sciences","55","5",,"1396","1405",,33,10.1007/s10620-009-0839-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953635401&doi=10.1007%2fs10620-009-0839-8&partnerID=40&md5=b2c479aea102c54e0556b5163c8f4efd",Article,Scopus,2-s2.0-77953635401
"Koyanagi, K., O'Day, S.J., Boasberg, P., Atkins, M.B., Wang, H.-J., Gonzalez, R., Lewis, K., Thompson, J.A., Anderson, C.M., Lutzky, J., Amatruda, T.T., Hersh, E., Richards, J., Weber, J.S., Hoon, D.S.B.","Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma",2010,"Clinical Cancer Research","16","8",,"2402","2408",,35,10.1158/1078-0432.CCR-10-0037,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950968549&doi=10.1158%2f1078-0432.CCR-10-0037&partnerID=40&md5=f04135b0c4ea1f241713d1f2ccf9efc9",Article,Scopus,2-s2.0-77950968549
"Clark, J.I., Moon, J., Hutchins, L.F., Sosman, J.A., Kast, W.M., Da Silva, D.M., Liu, P.Y., Thompson, J.A., Flaherty, L.E., Sondak, V.K.","Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508",2010,"Cancer","116","2",,"424","431",,13,10.1002/cncr.24739,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-75649095671&doi=10.1002%2fcncr.24739&partnerID=40&md5=d3cf8c8762babe6e79cca77cb7f95f47",Article,Scopus,2-s2.0-75649095671
"O'Day, S.J., Atkins, M.B., Boasberg, P., Wang, H.-J., Thompson, J.A., Anderson, C.M., Gonzalez, R., Lutzky, J., Amatruda, T., Hersh, E.M., Weber, J.S.","Phase II multicenter trial of maintenance biotherapy after induction concurrent biochemotherapy for patients with metastatic melanoma",2009,"Journal of Clinical Oncology","27","36",,"6207","6212",,28,10.1200/JCO.2008.20.3075,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-74949089360&doi=10.1200%2fJCO.2008.20.3075&partnerID=40&md5=50877eb0ba39108ea0b784d0e2c27de6",Article,Scopus,2-s2.0-74949089360
"Thompson, J.A.","Metastatic renal cell carcinoma: Current standards of care",2009,"Clinical Journal of Oncology Nursing","13","SUPPL. 6",,"8","12",,2,10.1188/09.CJON.S2.8-12,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77949523132&doi=10.1188%2f09.CJON.S2.8-12&partnerID=40&md5=5d15afcc8cade67c0abe21db7633f405",Article,Scopus,2-s2.0-77949523132
"Thompson, J.A., Kuzel, T., Drucker, B.J., Urba, W., Bukowski, R.","Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study",2009,"Clinical Genitourinary Cancer","7","3",,"E58","E65",,26,10.3816/CGC.2009.n.025,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-70449127697&doi=10.3816%2fCGC.2009.n.025&partnerID=40&md5=e37f4413fffcdad50657e8600fb15166",Article,Scopus,2-s2.0-70449127697
"Weber, J., Thompson, J.A., Hamid, O., Minor, D., Amin, A., Ron, I., Ridolfi, R., Assi, H., Maraveyas, A., Berman, D., Siegel, J., O'Day, S.J.","A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma",2009,"Clinical Cancer Research","15","17",,"5591","5598",,285,10.1158/1078-0432.CCR-09-1024,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-69949095926&doi=10.1158%2f1078-0432.CCR-09-1024&partnerID=40&md5=fb3b48d6c297ed5b22c1554b85eba24d",Article,Scopus,2-s2.0-69949095926
"Motzer, R.J., Hutson, T.E., Tomczak, P., Michaelson, M.D., Bukowski, R.M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G.A., Garcia-del-Muro, X., Sosman, J.A., Solska, E., Wilding, G., Thompson, J.A., Kim, S.T., Chen, I., Huang, X., Figlin, R.A.","Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma",2009,"Journal of Clinical Oncology","27","22",,"3584","3590",,1368,10.1200/JCO.2008.20.1293,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949145218&doi=10.1200%2fJCO.2008.20.1293&partnerID=40&md5=b3309fbb5974f999fa68aefd3e81efcf",Article,Scopus,2-s2.0-68949145218
"Dodds, M.G., Frederiksen, K.S., Skak, K., Hansen, L.T., Lundsgaard, D., Thompson, J.A., Hughes, S.D.","Immune activation in advanced cancer patients treated with recombinant IL-21: Multianalyte profiling of serum proteins",2009,"Cancer Immunology, Immunotherapy","58","6",,"843","854",,17,10.1007/s00262-008-0600-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-63949086742&doi=10.1007%2fs00262-008-0600-8&partnerID=40&md5=19a627d2e1ff32280d16cd8626800761",Article,Scopus,2-s2.0-63949086742
"Bhatia, S., Tykodi, S.S., Thompson, J.A.","Treatment of metastatic melanoma: An overview",2009,"ONCOLOGY","23","6",,"488","496",,228,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-67650491811&partnerID=40&md5=6a0d86f0ac71b5ea5468f41a2b5958dc",Review,Scopus,2-s2.0-67650491811
"Wallen, H., Thompson, J.A., Reilly, J.Z., Rodmyre, R.M., Cao, J., Yee, C.","Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma",2009,"PLoS ONE","4","3", e4749,"","",,55,10.1371/journal.pone.0004749,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-62749185585&doi=10.1371%2fjournal.pone.0004749&partnerID=40&md5=469aa08e1001e8766f56e9ca3a03b1a7",Article,Scopus,2-s2.0-62749185585
"Coit, D.G., Andtbacka, R., Bichakjian, C.K., Dilawari, R.A., DiMaio, D., Guild, V., Halpern, A.C., Hodi, F.S., Kashani-Sabet, M., Lange, J.R., Lind, A., Martin, L., Martini, M.C., Pruitt, S.K., Ross, M.I., Sener, S.F., Swetter, S.M., Tanabe, K.K., Thompson, J.A., Trisal, V., Urist, M.M., Weber, J., Wong, M.K.","Melanoma",2009,"JNCCN Journal of the National Comprehensive Cancer Network","7","3",,"250","275",,98,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-63449127290&partnerID=40&md5=51e9207cc45a02629e8e718bee4f9f2a",Article,Scopus,2-s2.0-63449127290
"Bhatia, S., Huber, B.R., Upton, M.P., Thompson, J.A.","Inflammatory enteric neuropathy with severe constipation after ipilimumab treatment for melanoma: A case report",2009,"Journal of Immunotherapy","32","2",,"203","205",,37,10.1097/CJI.0b013e318193a206,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-63649143542&doi=10.1097%2fCJI.0b013e318193a206&partnerID=40&md5=cd797d18227bbed97fda737d18092101",Article,Scopus,2-s2.0-63649143542
"Bhatia, S., Thompson, J.A.","Temsirolimus in patients with advanced renal cell carcinoma: An overview",2009,"Advances in Therapy","26","1",,"55","67",,17,10.1007/s12325-008-0138-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-73449084100&doi=10.1007%2fs12325-008-0138-3&partnerID=40&md5=9e68c07bdba95a8e2a1326497c84347d",Review,Scopus,2-s2.0-73449084100
"Tykodi, S.S., Thompson, J.A.","Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer",2008,"Expert Opinion on Biological Therapy","8","12",,"1947","1953",,10,10.1517/14712590802567298,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-57649242612&doi=10.1517%2f14712590802567298&partnerID=40&md5=9a642d7db58fca0eab77806d0e8d0187",Review,Scopus,2-s2.0-57649242612
"Thompson, J.A., Curti, B.D., Redman, B.G., Bhatia, S., Weber, J.S., Agarwala, S.S., Sievers, E.L., Hughes, S.D., Devries, T.A., Hausman, D.F.","Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma",2008,"Journal of Clinical Oncology","26","12",,"2034","2039",,115,10.1200/JCO.2007.14.5193,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-42949139835&doi=10.1200%2fJCO.2007.14.5193&partnerID=40&md5=a6b24ecf23b27681b0d42d620eb4be79",Article,Scopus,2-s2.0-42949139835
"Tykodi, S.S., Fujii, N., Vigneron, N., Lu, S.M., Mito, J.K., Miranda, M.X., Chou, J., Voong, L.N., Thompson, J.A., Sandmaier, B.M., Cresswell, P., Van Eynde, B.D., Riddel, S.R., Warren, E.H.","C19orf48 encodes a minor histocompatibility antigen recognized by CD8 + cytotoxic T cells from renal cell carcinoma patients",2008,"Clinical Cancer Research","14","16",,"5260","5269",,34,10.1158/1078-0432.CCR-08-0028,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-52649143709&doi=10.1158%2f1078-0432.CCR-08-0028&partnerID=40&md5=7c42965855108c9fd050c557b4b292e0",Article,Scopus,2-s2.0-52649143709
"Motzer, R.J., Escudier, B., Oudard, S., Hutson, T.E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J.A., Figlin, R.A., Hollaender, N., Urbanowitz, G., Berg, W.J., Kay, A., Lebwohl, D., Ravaud, A.","Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial",2008,"The Lancet","372","9637",,"449","456",,1996,10.1016/S0140-6736(08)61039-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-48649107474&doi=10.1016%2fS0140-6736%2808%2961039-9&partnerID=40&md5=95d11dd8a5da21d524336847c3e9d6db",Article,Scopus,2-s2.0-48649107474
"Hunder, N.N., Wallen, H., Cao, J., Hendricks, D.W., Reilly, J.Z., Rodmyre, R., Jungbluth, A., Gnjatic, S., Thompson, J.A., Yee, C.","Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1",2008,"New England Journal of Medicine","358","25",,"2698","2703",,512,10.1056/NEJMoa0800251,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-45549099784&doi=10.1056%2fNEJMoa0800251&partnerID=40&md5=81749b6b63024051ecd032c54855306a",Article,Scopus,2-s2.0-45549099784
"Thompson, J.A., Fisher, R.I., LeBlanc, M., Forman, S.J., Press, O.W., Unger, J.M., Nademanee, A.P., Stiff, P.J., Petersdorf, S.H., Fefer, A.","Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-hodgkin lymphoma: Results of a phase 3 randomized trial by the southwest oncology group (SWOG 9438)",2008,"Blood","111","8",,"4048","4054",,13,10.1182/blood-2007-09-111708,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-43249088822&doi=10.1182%2fblood-2007-09-111708&partnerID=40&md5=dd53249a87e555ceb1f0f6a368a761e7",Article,Scopus,2-s2.0-43249088822
"Hutchins, L.F., Moon, J., Clark, J.I., Thompson, J.A., Lange, M.K., Flaherty, L.E., Sondak, V.K.","Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026",2007,"Cancer","110","10",,"2269","2275",,10,10.1002/cncr.23035,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-36148980118&doi=10.1002%2fcncr.23035&partnerID=40&md5=ebb77cbaae2f2c15b94bc3d30d59a5c0",Article,Scopus,2-s2.0-36148980118
"Mitchell, M.S., Abrams, J., Thompson, J.A., Kashani-Sabet, M., DeConti, R.C., Hwu, W.-J., Atkins, M.B., Whitman, E., Ernstoff, M.S., Haluska, F.G., Jakowatz, J.G., Das Gupta, T.K., Richards, J.M., Samlowski, W.E., Costanzi, J.J., Aronson, F.R., Deisseroth, A.B., Dudek, A.Z., Jones, V.E.","Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma",2007,"Journal of Clinical Oncology","25","15",,"2078","2085",,56,10.1200/JCO.2006.10.1709,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249941065&doi=10.1200%2fJCO.2006.10.1709&partnerID=40&md5=382f153e74af833b97f5ef0c951fc974",Article,Scopus,2-s2.0-34249941065
"Yee, C., Wallen, H., Hunder, N., Thompson, J.A., Byrd, D., Reilly, J.Z., Hendricks, D., Kenyon, K., Schirmer, L.","Recent advances in the use of antigen-specific T cells for the treatment of cancer",2006,"Update on Cancer Therapeutics","1","3",,"333","342",,3,10.1016/j.uct.2006.06.002,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748525219&doi=10.1016%2fj.uct.2006.06.002&partnerID=40&md5=257467232d24735acebfa579f251731e",Review,Scopus,2-s2.0-33748525219
"Houghton, A.N., Coit, D.G., Daud, A., Dilawari, R.A., DiMaio, D., Gollob, J.A., Haas, N.B., Halpern, A., Johnson, T.M., Kashani-Sabet, M., Kraybill, W.G., Lange, J.R., Martini, M., Ross, M.I., Samlowski, W.E., Sener, S.F., Tanabe, K.K., Thompson, J.A., Trisal, V., Urist, M.M., Walker, M.J.","Melanoma: Clinical practice guidelines in oncology™",2006,"JNCCN Journal of the National Comprehensive Cancer Network","4","7",,"666","684",,22,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747681022&partnerID=40&md5=85cf21b7cfe908fa08c8576d1537e6da",Review,Scopus,2-s2.0-33747681022
"Stadler, W.M., Margolin, K., Ferber, S., McCulloch, W., Thompson, J.A.","A phase II study of depsipeptide in refractory metastatic renal cell cancer",2006,"Clinical Genitourinary Cancer","5","1",,"57","60",,109,10.3816/CGC.2006.n.018,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749049594&doi=10.3816%2fCGC.2006.n.018&partnerID=40&md5=09f0f18f95a6599be208eebcae22b0ac",Article,Scopus,2-s2.0-33749049594
"Dummer, R., Garbe, C., Thompson, J.A., Eggermont, A.M., Yoo, K., Maier, T., Bergstrom, B.","Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma",2006,"Journal of Clinical Oncology","24","7",,"1188","1194",,47,10.1200/JCO.2005.04.3216,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644970827&doi=10.1200%2fJCO.2005.04.3216&partnerID=40&md5=13be88bf986afffc5d3cda0e6faf4a09",Article,Scopus,2-s2.0-33644970827
"Lewis, K.D., Thompson, J.A., Weber, J.S., Robinson, W.A., O'Day, S., Lutzky, J., Legha, S.S., Floret, S., Ruvuna, F., Gonzalez, R.","A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma",2006,"Investigational New Drugs","24","1",,"89","94",,9,10.1007/s10637-005-4544-y,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-31544457606&doi=10.1007%2fs10637-005-4544-y&partnerID=40&md5=cef366373c2f6ebebe2150239b9344ea",Article,Scopus,2-s2.0-31544457606
"Lush, R.M., McCune, J.S., Tetteh, L., Thompson, J.A., Mahany, J.J., Garland, L., Suttle, A.B., Sullivan, D.M.","The absolute bioavailability of oral vinorelbine in patients with solid tumors",2005,"Cancer Chemotherapy and Pharmacology","56","6",,"578","584",,19,10.1007/s00280-005-1025-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-26444533541&doi=10.1007%2fs00280-005-1025-0&partnerID=40&md5=c22d8cbdbb559c18791aeb5bae6ee932",Article,Scopus,2-s2.0-26444533541
"Ettinger, D.S., Arnoletti, J.P., Gockerman, J.P., Handorf, C., Havlin, K.A., Jacobs, C.D., Javle, M., Kvols, L., Lenzi, R., Rashid, A., Rhoades, C.A., Ridge, J.A., Saltz, L., Shulman, L.N., Sondak, V.K., Thompson, J.A., Twardowski, P., Zhen, W.","Occult primary cancer: Clinical practice guidelines",2005,"JNCCN Journal of the National Comprehensive Cancer Network","3","2",,"214","233",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747585840&partnerID=40&md5=f81070997f5bf434f2772697c047bffc",Review,Scopus,2-s2.0-33747585840
"Tykodi, S.S., Warren, E.H., Thompson, J.A., Riddell, S.R., Childs, R.W., Otterud, B.E., Leppert, M.F., Storb, R., Sandmaier, B.M.","Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: Toxicity, clinical response, and immunological response to minor histocompatibility antigens",2004,"Clinical Cancer Research","10","23",,"7799","7811",,81,10.1158/1078-0432.CCR-04-0072,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-5444224775&doi=10.1158%2f1078-0432.CCR-04-0072&partnerID=40&md5=f110d6a8eed03fe7f953ed4dfaaef53d",Article,Scopus,2-s2.0-5444224775
"Rowinsky, E.K., Schwartz, G.H., Gollob, J.A., Thompson, J.A., Vogelzang, N.J., Figlin, R., Bukowski, R., Haas, N., Lockbaum, P., Li, Y.-P., Arends, R., Foon, K.A., Schwab, G., Dutcher, J.","Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer",2004,"Journal of Clinical Oncology","22","15",,"3003","3015",,287,10.1200/JCO.2004.11.061,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-4143050397&doi=10.1200%2fJCO.2004.11.061&partnerID=40&md5=c20130356a16fda074177125353eb092",Article,Scopus,2-s2.0-4143050397
"Walter, R.B., Raden, B.W., Thompson, J., Flowers, D.A., Kiem, H.-P., Bernstein, I.D., Linenberger, M.L.","Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-γ1 in acute myeloid leukemia cells [6]",2004,"Leukemia","18","11",,"1914","1917",,13,10.1038/sj.leu.2403461,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-8844238363&doi=10.1038%2fsj.leu.2403461&partnerID=40&md5=14eb373cc74afb9be24976f1ad62017f",Letter,Scopus,2-s2.0-8844238363
"Balch, C.M., Soong, S.-J., Atkins, M.B., Buzaid, A.C., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton Jr., A., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson, J.F.","An evidence-based staging system for cutaneous melanoma",2004,"Ca-A Cancer Journal for Clinicians","54","3",,"131","149",,286,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042666881&partnerID=40&md5=0cb8c3681ae82b613a836da1827454fd",Article,Scopus,2-s2.0-3042666881
"Foon, K.A., Yang, X.-D., Weiner, L.M., Belldegrun, A.S., Figlin, R.A., Crawford, J., Rowinsky, E.K., Dutcher, J.P., Vogelzang, N.J., Gollub, J., Thompson, J.A., Schwartz, G., Bukowski, R.M., Roskos, L.K., Schwab, G.M.","Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody",2004,"International Journal of Radiation Oncology Biology Physics","58","3",,"984","990",,187,10.1016/j.ijrobp.2003.09.098,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744221013&doi=10.1016%2fj.ijrobp.2003.09.098&partnerID=40&md5=13acc5dedd75c7b185fb1acd0e08dcfc",Conference Paper,Scopus,2-s2.0-10744221013
"Thompson, J.A., Figlin, R.A., Sifri-Steele, C., Berenson, R.J., Frohlich, M.W.","A phase I trial of CD3/CD28-activated T Cells (Xcellerated T Cells) and interleukin-2 in patients with metastatic renal cell carcinoma",2003,"Clinical Cancer Research","9","10 I",,"3562","3570",,56,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141456489&partnerID=40&md5=53dbaaeee1a90a65da675187b44dc8a5",Article,Scopus,2-s2.0-0141456489
"Balch, C.M., Buzaid, A.C., Soong, S.-J., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton Jr., A., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson, J.F.","New TNM melanoma staging system: Linking biology and natural history to clinical outcomes",2003,"Seminars in Surgical Oncology","21","1",,"43","52",,99,10.1002/ssu.10020,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744230605&doi=10.1002%2fssu.10020&partnerID=40&md5=8142db88318283f633ba788a913752ed",Review,Scopus,2-s2.0-10744230605
"Balch, C.M., Sober, A.J., Soong, S.-J., Gershenwald, J.E., Buzaid, A.C., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Houghton Jr., A., Kirkwood, J.M., McMasters, K.M., Mihm Jr., M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Thompson, J.A., Thompson, J.F.","The new melanoma staging system",2003,"Seminars in Cutaneous Medicine and Surgery","22","1",,"42","54",,24,10.1053/sder.2003.50004,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037693973&doi=10.1053%2fsder.2003.50004&partnerID=40&md5=a9bf542252bccda3b15a95a536b30224",Review,Scopus,2-s2.0-0037693973
"Thompson, J.","Protocol #0207-544: a phase study to evaluate the safety and pharmacokinetics of Pro-1, a liposome-encapsulated thymidine kinase gene formulation, in patients with stage IV metastatic melanoma.",2003,"Human gene therapy","14","3",,"310","312",,3,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141449290&partnerID=40&md5=4c005d3fd261c0fe5f439f7717f053d5",Article,Scopus,2-s2.0-0141449290
"Yee, C., Thompson, J.A., Byrd, D., Riddell, S.R., Roche, P., Celis, E., Greenberg, P.D.","Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells",2002,"Proceedings of the National Academy of Sciences of the United States of America","99","25",,"16168","16173",,828,10.1073/pnas.242600099,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037058993&doi=10.1073%2fpnas.242600099&partnerID=40&md5=a8eb52c4d55ae56fabfeb057adc0ca3c",Article,Scopus,2-s2.0-0037058993
"Warren, E.H., Tykodi, S.S., Murata, M., Sandmaier, B.M., Storb, R., Jaffee, E., Childs, R., Thompson, J.A., Greenberg, P.D., Riddell, S.R.","T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma",2002,"Cytotherapy","4","5",,"441","",,10,10.1080/146532402320776116,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-18744402159&doi=10.1080%2f146532402320776116&partnerID=40&md5=33c97dd668c4340af1b58eccaabe335e",Conference Paper,Scopus,2-s2.0-18744402159
"Motzer, R.J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K., Hooftman, L.","Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma",2002,"Annals of Oncology","13","11",,"1799","1805",,42,10.1093/annonc/mdf288,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036861799&doi=10.1093%2fannonc%2fmdf288&partnerID=40&md5=433cecbc8698809b037e935d40288d29",Article,Scopus,2-s2.0-0036861799
"Thompson, J.A.","The revised American Joint Committee on Cancer staging system for melanoma",2002,"Seminars in Oncology","29","4",,"361","369",,25,10.1053/sonc.2002.34115,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036340798&doi=10.1053%2fsonc.2002.34115&partnerID=40&md5=b98b765f3a7c40d06dc07bda896bb6d8",Article,Scopus,2-s2.0-0036340798
"Masood, N., Russell, K.J., Olerud, J.E., Sabath, D.E., Sale, G.E., Doney, K.C., Flowers, M.E.D., Fefer, A., Thompson, J.A.","Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation",2002,"Journal of the American Academy of Dermatology","47","1",,"140","145",,22,10.1067/mjd.2002.122188,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036658294&doi=10.1067%2fmjd.2002.122188&partnerID=40&md5=c31786249c2589384656aaa067791f80",Article,Scopus,2-s2.0-0036658294
"Margolin, K., Atkins, M., Thompson, J., Ernstoff, M., Weber, J., Flaherty, L., Clark, J., Weiss, G., Sosman, J., Smith, J., Dutcher, J., Gollob, J., Longmate, J., Johnson, D.","Temozolomide and whole brain irradiation in melanoma metastatic to the brain: A phase II trial of the Cytokine Working Group",2002,"Journal of Cancer Research and Clinical Oncology","128","4",,"214","218",,115,10.1007/s00432-002-0323-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036208833&doi=10.1007%2fs00432-002-0323-8&partnerID=40&md5=5e098f72c95f002921bc9e0e8edf9beb",Article,Scopus,2-s2.0-0036208833
"Sosman, J.A., Unger, J.M., Liu, P.-Y., Flaherty, L.E., Park, M.S., Kempf, R.A., Thompson, J.A., Terasaki, P.I., Sondak, V.K.","Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome",2002,"Journal of Clinical Oncology","20","8",,"2067","2075",,165,10.1200/JCO.2002.08.072,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037089672&doi=10.1200%2fJCO.2002.08.072&partnerID=40&md5=9d008d120af21fd7621fbe007750db3d",Article,Scopus,2-s2.0-0037089672
"Sondak, V.K., Liu, P.-Y., Tuthill, R.J., Kempf, R.A., Unger, J.M., Sosman, J.A., Thompson, J.A., Weiss, G.R., Redman, B.G., Jakowatz, J.G., Noyes, R.D., Flaherty, L.E.","Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Overall results of a randomized trial of the Southwest Oncology Group",2002,"Journal of Clinical Oncology","20","8",,"2058","2066",,170,10.1200/JCO.2002.08.071,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037089687&doi=10.1200%2fJCO.2002.08.071&partnerID=40&md5=dd87ca89a96eed9b3072257470acfec6",Article,Scopus,2-s2.0-0037089687
"Balch, C.M., Buzaid, A.C., Soong, S.-J., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Gershenwald, J.E., Houghton A., Jr., Kirkwood, J.M., McMasters, K.M., Mihm, M.F., Morton, D.L., Reintgen, D.S., Ross, M.I., Sober, A., Thompson, J.A., Thompson, J.F.","Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma",2001,"Journal of Clinical Oncology","19","16",,"3635","3648",,2020,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035881074&partnerID=40&md5=ec777ca39494ffdfbea5df2fa3d0fae3",Article,Scopus,2-s2.0-0035881074
"Balch, C.M., Soong, S.-J., Gershenwald, J.E., Thompson, J.F., Reintgen, D.S., Cascinelli, N., Urist, M., McMasters, K.M., Ross, M.I., Kirkwood, J.M., Atkins, M.B., Thompson, J.A., Coit, D.G., Byrd, D., Desmond, R., Zhang, Y., Liu, P.-Y., Lyman, G.H., Morabito, A.","Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system",2001,"Journal of Clinical Oncology","19","16",,"3622","3634",,1640,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035880957&partnerID=40&md5=8c2875dd3be65bea60f4957dac2c0e70",Article,Scopus,2-s2.0-0035880957
"Motzer, R.J., Rakhit, A., Thompson, J.A., Nemunaitis, J., Murphy, B.A., Ellerhorst, J., Schwartz, L.H., Berg, W.J., Bukowski, R.M.","Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-α2a for patients with advanced renal cell carcinoma",2001,"Journal of Interferon and Cytokine Research","21","4",,"257","263",,84,10.1089/107999001750169934,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034917186&doi=10.1089%2f107999001750169934&partnerID=40&md5=c93233d194eb8f206becc5b7af1f94ac",Article,Scopus,2-s2.0-0034917186
"Stopeck, A.T., Jones, A., Hersh, E.M., Thompson, J.A., Finucane, D.M., Gutheil, J.C., Gonzalez, R.","Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanoma",2001,"Clinical Cancer Research","7","8",,"2285","2291",,100,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034885426&partnerID=40&md5=c86590f0dc05f7e709e338ac04fbbed5",Article,Scopus,2-s2.0-0034885426
"Yee, C., Thompson, J.A., Roche, P., Byrd, D.R., Lee, P.P., Piepkorn, M., Kenyon, K., Davis, M.M., Riddell, S.R., Greenberg, P.D.","Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo",2000,"Journal of Experimental Medicine","192","11",,"1637","1643",,340,10.1084/jem.192.11.1637,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034606276&doi=10.1084%2fjem.192.11.1637&partnerID=40&md5=0f7ba8ea9d723f85bee8f89c42369e1c",Article,Scopus,2-s2.0-0034606276
"Jacobs, A., Gold, P., Weiden, P., Aboulafia, D., Rudolph, R., Picozzi, V., Thompson, J.","Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer",2000,"Cancer Investigation","18","5",,"417","421",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034038715&partnerID=40&md5=754984b51547f80acfe431731f9d4e7e",Article,Scopus,2-s2.0-0034038715
"Balch, C.M., Buzaid, A.C., Atkins, M.B., Cascinelli, N., Coit, D.G., Fleming, I.D., Houghton Jr., A., Kirkwood, J.M., Mihm, M.F., Morton, D.L., Reintgen, D., Ross, M.I., Sober, A., Soong, S.-J., Thompson, J.A., Thompson, J.F., Gershenwald, J.E., McMasters, K.M.","A new American Joint Committee on Cancer staging system for cutaneous melanoma",2000,"Cancer","88","6",,"1484","1491",,368,10.1002/(SICI)1097-0142(20000315)88:6&lt;1484::AID-CNCR29&gt;3.0.CO;2-D,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-17544401946&doi=10.1002%2f%28SICI%291097-0142%2820000315%2988%3a6%26lt%3b1484%3a%3aAID-CNCR29%26gt%3b3.0.CO%3b2-D&partnerID=40&md5=e3729158ae87bf512cc2b216ef94e50d",Article,Scopus,2-s2.0-17544401946
"Thompson, J.A., Gilliland, D.G., Prchal, J.T., Bennett, J.M., Larholt, K., Nelson, R.A., Rose, E.H., Dugan, M.H.","Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome",2000,"Blood","95","4",,"1175","1179",,83,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034651839&partnerID=40&md5=697f85d8804d05e3c0736c9de1b00214",Article,Scopus,2-s2.0-0034651839
"Xun, C.Q., McSweeney, P.A., Boeckh, M., Storb, R.F., Thompson, J.A., Broudy, V.C.","Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis [4]",1999,"Blood","94","9",,"3273","3276",,33,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033230377&partnerID=40&md5=b7c85f1f9b8fc2a01be199f78a9d824c",Letter,Scopus,2-s2.0-0033230377
"Figlin, R.A., Thompson, J.A., Bukowski, R.M., Vogelzang, N.J., Novick, A.C., Lange, P., Steinberg, G.D., Belldegrun, A.S.","Multicenter, randomized, phase III trial of CD8+ tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma",1999,"Journal of Clinical Oncology","17","8",,"2521","2529",,162,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032784492&partnerID=40&md5=ee46f636b8589fa113783d4c56084d90",Article,Scopus,2-s2.0-0032784492
"Lee, P.P., Yee, C., Savage, P.A., Fong, L., Brockstedt, D., Weber, J.S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P.D., Roederer, M., Davis, M.M.","Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients",1999,"Nature Medicine","5","6",,"677","685",,844,10.1038/9525,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033056073&doi=10.1038%2f9525&partnerID=40&md5=d4895beaefb0b1be51d8b8902c9abdc7",Article,Scopus,2-s2.0-0033056073
"Houghton, A., Coit, D., Bloomer, W., Buzaid, A., Chu, D., Eisenberg, B., Guitart, J., Johnson, T., Miller, S., Sener, S., Tanabe, K., Thompson, J., Urist, M., Walker, M.","NGGN Melanoma Practice Guidelines",1998,"ONCOLOGY","12","7 A",,"153","177",,57,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031828737&partnerID=40&md5=eecee1cf604ba9b10c73f4d12422117b",Article,Scopus,2-s2.0-0031828737
"Whitehead, R.P., Unger, J.M., Wendall Goodwin, J., Walker, M.J., Thompson, J.A., Flaherty, L.E., Sondak, V.K.","Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: A southwest oncology group study",1998,"Journal of Immunotherapy","21","6",,"440","446",,37,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031786674&partnerID=40&md5=8d6af1b223f3294f0e6e21e6b14c098c",Article,Scopus,2-s2.0-0031786674
"Gold, P.J., Thompson, J.A., Markowitz, D.R., Neumann, S., Fefer, A.","Metastatic renal cell carcinoma: Long-term survival after therapy with high-dose continuous-infusion interleukin-2",1997,"Cancer Journal from Scientific American","3","SUPPL. 1",,"S85","S91",,29,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031431092&partnerID=40&md5=2b569051feb3fa8fec7b9ce99ca94668",Article,Scopus,2-s2.0-0031431092
"Fefer, A., Robinson, N., Benyunes, M.C., Bensinger, W.I., Press, O., Thompson, J.A., Lindgren, C.","Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies",1997,"Cancer Journal from Scientific American","3","SUPPL. 1",,"S48","S53",,26,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031416082&partnerID=40&md5=5e40d3ef5169db6efd55af72e2ece67f",Article,Scopus,2-s2.0-0031416082
"Mankoff, D.A., Thompson, J.A., Gold, P., Eary, J.F., Guinee Jr., D.G., Samlowski, W.E.","Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor",1997,"American Journal of Roentgenology","169","4",,"1049","1050",,7,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030924119&partnerID=40&md5=21a002d278c3aadab4152572eb6a56ea",Article,Scopus,2-s2.0-0030924119
"Lindgren, C.G., Thompson, J.A., Robinson, N., Keeler, T., Gold, P.J., Fefer, A.","Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants",1997,"Bone Marrow Transplantation","19","9",,"867","873",,11,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030962718&partnerID=40&md5=329599715c165f1babafa1609588c345",Article,Scopus,2-s2.0-0030962718
"Robinson, N., Benyunes, M.C., Thompson, J.A., York, A., Petersdorf, S., Press, O., Lindgren, C., Chauncey, T., Buckner, C.D., Bensinger, W.I., Appelbaum, F.R., Fefer, A.","Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: A phase I/II study",1997,"Bone Marrow Transplantation","19","5",,"435","442",,39,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031047464&partnerID=40&md5=359d09a865477344420d11307d3c4066",Article,Scopus,2-s2.0-0031047464
"Thompson, J.A., Gold, P.J., Fefer, A.","Outpatient chemoimmunotherapy for the treatment of metastatic melanoma",1997,"Seminars in Oncology","24","1 SUPPL. 4",,"S4","44-S4-48",,27,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031064875&partnerID=40&md5=a62558433ec35e7706554d0326cafce1",Review,Scopus,2-s2.0-0031064875
"Thompson, J.A., Gold, P.J., Markowitz, D.R., Byrd, D.R., Lindgren, C.G., Fefer, A.","Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma",1997,"Cancer Journal from Scientific American","3","SUPPL. 1",,"S29","S34",,37,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031424974&partnerID=40&md5=f6f22749d175783bb805e88ad1a3087a",Article,Scopus,2-s2.0-0031424974
"Gold, P.J., Fefer, A., Thompson, J.A.","Paraneoplastic manifestations of renal cell carcinoma",1996,"Seminars in Urologic Oncology","14","4",,"216","222",,84,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029855450&partnerID=40&md5=6a48d26d83ec77e40734ba9754f13ef0",Review,Scopus,2-s2.0-0029855450
"Yee, C., Gilbert, M.J., Riddell, S.R., Brichard, V.G., Fefer, A., Thompson, J.A., Boon, T., Greenberg, P.D.","Isolation of Tyrosinase-Specific CD8+ and CD4+ T Cell Clones from the Peripheral Blood of Melanoma Patients Following in Vitro Stimulation with Recombinant Vaccinia Virus",1996,"Journal of Immunology","157","9",,"4079","4086",,85,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030293623&partnerID=40&md5=3e8faab57d229e1c843a4a00d1b6ca70",Article,Scopus,2-s2.0-0030293623
"Massumoto, C., Benyunes, M.C., Sale, G., Beauchamp, M., York, A., Thompson, J.A., Buckner, C.D., Fefer, A.","Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy",1996,"Bone Marrow Transplantation","17","3",,"351","356",,46,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029865505&partnerID=40&md5=d8f4602c0326a33f36c1b7e14ca95d9f",Article,Scopus,2-s2.0-0029865505
"Robinson, N., Sanders, J.E., Benyunes, M.C., Beach, K., Lindgren, C., Thompson, J.A., Appelbaum, F.R., Fefer, A.","Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia",1996,"Blood","87","4",,"1249","1254",,36,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030019977&partnerID=40&md5=62654241ab87ebdd584d018cbb087e23",Article,Scopus,2-s2.0-0030019977
"Benyunes, M.C., Higuchi, C., York, A., Lindgren, C., Thompson, J.A., Buckner, C.D., Fefer, A.","Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: A feasibility trial",1995,"Bone Marrow Transplantation","16","2",,"283","288",,67,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029099188&partnerID=40&md5=77b1112d35b6bb1b28aae2ef5debdb69",Article,Scopus,2-s2.0-0029099188
"Fefer, A., Benyunes, M.C., York, A., Buckner, D., Thompson, J.A.","Use of interleukin-2 after bone marrow transplantation",1995,"Bone Marrow Transplantation","15","SUPPL. 1",,"S162","S166",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029060870&partnerID=40&md5=05022c0f65bc7fd1aae1bad99128e757",Conference Paper,Scopus,2-s2.0-0029060870
"Sosman, J.A., Flaherty, L.E., Liu, P.Y., Fletcher, W., Thompson, J.A., Hantel, A., Sondak, V.","A phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study",1995,"Investigational New Drugs: An Interdisciplinary Journal for Clinicians and Scientists","13","1",,"83","87",,3,10.1007/BF02614226,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029133416&doi=10.1007%2fBF02614226&partnerID=40&md5=c7dbdc08d15523c8992fb2955fbb699c",Article,Scopus,2-s2.0-0029133416
"Benyunes, M.C., Thompson, J.A., York, A., Buckner, C.D., Fefer, A.","Immunotherapy with interleukin-2 after autologous bone marrow transplantation for hematologic malignancies.",1994,"Progress in clinical and biological research","389",,,"229","238",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028717675&partnerID=40&md5=e9cb8edbd2482d70ce4ca4748bc47a94",Review,Scopus,2-s2.0-0028717675
"Kovach, N.L., Lindgren, C.G., Fefer, A., Thompson, J.A., Yednock, T., Harlan, J.M.","Pentoxifylline inhibits integrin-mediated adherence of interleukin-2-activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells",1994,"Blood","84","7",,"2234","2242",,25,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027981952&partnerID=40&md5=32b68d41cba1e84ee38c4df0068f6cce",Article,Scopus,2-s2.0-0027981952
"Neubauer, M.A., Benyunes, M.C., Thompson, J.A., Bensinger, W.I., Lindgren, C.G., Buckner, C.D., Fefer, A.","Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation",1994,"Bone Marrow Transplantation","13","3",,"311","316",,39,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028089348&partnerID=40&md5=ee7121c13fad0a174d0d1450bff8c3a8",Article,Scopus,2-s2.0-0028089348
"Thompson, J.A., Bianco, J.A., Neubauer, M.A., Fefer, A.","Phase lb Trial of Pentoxifylline and Ciprofloxacin in Patients Treated with Interleukin-2 and Lymphokine-activated Killer Cell Therapy for Metastatic Renal Cell Carcinoma",1994,"Cancer Research","54","13",,"3436","3441",,29,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028228294&partnerID=40&md5=efce1b63bfa5a2d2a014c06e44fd0253",Article,Scopus,2-s2.0-0028228294
"Thompson, J.A., Benyunes, M.C., Bianco, J.A., Fefer, A.","Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells",1993,"Seminars in Oncology","20","SUPPL. 9",,"46","51",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027770020&partnerID=40&md5=14b80b54b8d12a81bbebf1ef4a73388a",Article,Scopus,2-s2.0-0027770020
"Fefer, A., Benyunes, M.C., Massumoto, C., Higuchi, C., York, A., Buckner, C.D., Thompson, J.A.","Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies",1993,"Seminars in Oncology","20","SUPPL. 9",,"41","45",,31,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027772709&partnerID=40&md5=e3dd9ca291be97c139a293ebd558ced8",Review,Scopus,2-s2.0-0027772709
"Pavletic, Z., Benyunes, M.C., Thompson, J.A., Lindgren, C.G., Masumoto, C., alderson, M.R., Buckner, C.D., Fefer, A.","Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy",1993,"Experimental Hematology","21","10",,"1371","1378",,13,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027886329&partnerID=40&md5=47ca6fc85f38f3460d3bb211ea7c5b91",Article,Scopus,2-s2.0-0027886329
"Lindgren, C.G., Thompson, J.A., Higuchi, C.M., Fefer, A.","Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4",1993,"Journal of Immunotherapy","14","4",,"322","328",,6,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027386146&partnerID=40&md5=482d7daf0c2c6de3707a66da64738b6d",Article,Scopus,2-s2.0-0027386146
"Shulman, K.L., Thompson, J.A., Benyunes, M.C., Winter, T.C., Fefer, A.","Adverse reactions to intravenous contrast media in patients treated with interleukin-2",1993,"Journal of Immunotherapy","13","3",,"208","212",,33,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027416227&partnerID=40&md5=8da6c1a4598a749a763bdf34487f4a9f",Article,Scopus,2-s2.0-0027416227
"Thompson, J.A., Lindgren, C.G., Benyunes, M.C., Bianco, J.A., Shields, A.F., Fefer, A.","The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity",1993,"Journal of Immunotherapy","13","2",,"84","90",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027411905&partnerID=40&md5=27185346ebab6d99f6be4f00b25b0462",Article,Scopus,2-s2.0-0027411905
"Fefer, A., Benyunes, M., Higuchi, C., York, A., Massumoto, C., Lindgren, C., Buckner, C.D., Thompson, J.A.","Interleukin-2 ± lymphocytes as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies",1993,"Acta Haematologica","89",,,"2","7",,27,10.1159/000204577,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027162605&doi=10.1159%2f000204577&partnerID=40&md5=ed9677ae5eab7fb3bbc1961057e15521",Article,Scopus,2-s2.0-0027162605
"Benyunes, M.C., Massumoto, C., York, A., Higuchi, C.M., Buckner, C.D., Thompson, J.A., Petersen, F.B., Fefer, A.","Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia",1993,"Bone Marrow Transplantation","12","2",,"159","163",,94,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027301162&partnerID=40&md5=45d84bbe4adefe6f2ec777566cc4549b",Article,Scopus,2-s2.0-0027301162
"Thompson, J.A., Shulman, K.L., Benyunes, M.C., Lindgren, C.G., Collins, C., Lange, P.H., Bush Jr., W.H., Benz, L.A., Fefer, A.","Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma",1992,"Journal of Clinical Oncology","10","6",,"960","968",,56,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026717706&partnerID=40&md5=2a60d1a384053f5b5bb79acdc1dd492c",Article,Scopus,2-s2.0-0026717706
"Higuchi, C.M., Thompson, J.A., Petersen, F.B., Buckner, C.D., Fefer, A.","Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies",1991,"Blood","77","12",,"2561","2568",,95,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025784832&partnerID=40&md5=07f528026dab86a04526fa36fe7dd35c",Article,Scopus,2-s2.0-0025784832
"Golomb, H.M., Ratain, M.J., Fefer, A., Thompson, J., Portlock, C.S., Ozer, H., Mick, R., Chiavello, J., Israel, R.J., Bonnem, E.M.","Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients",1991,"leukemia &amp; lymphoma","5","6 --May",,"335","340",,2,10.3109/10428199109067626,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026320831&doi=10.3109%2f10428199109067626&partnerID=40&md5=aef675f9495c7793209e37a64a0269ce",Article,Scopus,2-s2.0-0026320831
"Golomb, H.M., Fefer, A., Golde, D.W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Ratain, M.J., Thompson, J., Bonnem, E., Spiegel, R., Tensen, L., Burke, J.S., Vardiman, J.W.","Survival experience of 195 patients with hairy cell leukemia treated in a multi-institutional study with interferon-alfa 2b",1991,"Leukemia and Lymphoma","4","2",,"99","102",,11,10.3109/10428199109068051,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025793843&doi=10.3109%2f10428199109068051&partnerID=40&md5=53acfc116ca3f5c29361657294827caf",Article,Scopus,2-s2.0-0025793843
"Treisman, J., Higuchi, C.M., Thompson, J.A., Lindgren, C.G., Kern, D.E., Ridell, S.R., Greenberg, P.D., Fefer, A., Gillis, S.","Enhancement by Interleukin 4 of Interleukin 2- or Antibody-induced Proliferation of Lymphocytes from Interleukin 2-treated Cancer Patients",1990,"Cancer Research","50","4",,"1160","1164",,19,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025166397&partnerID=40&md5=e62afb4abcd7bd09fed84a388a6d66bc",Article,Scopus,2-s2.0-0025166397
"Higuchi, C.M., Thompson, J.A., Lindgren, C.G., Kern, D.E., Fefer, A., Gillis, S., Widmer, M.B.","Induction of Lymphokine-activated Killer Activity by Interleukin 4 in Human Lymphocytes Preactivated by Interleukin 2 in Vivo or in Vitro",1989,"Cancer Research","49","23",,"6487","6492",,28,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024378805&partnerID=40&md5=65451188ca82787ba8b52d439b718281",Article,Scopus,2-s2.0-0024378805
"Higuchi, C.M., Thompson, J.A., Cox, T., Lindgren, C.G., Buckner, C.D., Fefer, A.","Lymphokine-activated Killer Function following Autologous Bone Marrow Transplantation for Refractory Hematological Malignancies",1989,"Cancer Research","49","20",,"5509","5513",,51,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024434793&partnerID=40&md5=a5bcefa39ef5065a56b83d9d4b67971d",Article,Scopus,2-s2.0-0024434793
"Thompson, J.A., Kidd, P., Rubin, E., Fefer, A.","Very low dose α-2b interferon for the treatment of hairy cell leukemia",1989,"Blood","73","6",,"1440","1443",,19,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024506978&partnerID=40&md5=0228dc3bbc578299126d4c41868b9a99",Article,Scopus,2-s2.0-0024506978
"Thompson, J.A., Lee, D.J., Kidd, P., Rubin, E., Kaufmann, J., Bonnem, E.M., Fefer, A.","Subcutaneous granulocyte-macrophage colony-stimulating factors in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematological effects",1989,"Journal of Clinical Oncology","7","5",,"629","637",,130,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024498901&partnerID=40&md5=11ca8b21bb89f0ebb85a3d9c55800bbb",Article,Scopus,2-s2.0-0024498901
"Thompson, J.A., Lee, D.J., Lindgren, C.G., Benz, L.A., Collins, C., Shuman, W.P., Leyitt, D., Fefer, A.","Influence of Schedule of Interleukin 2 Administration on Therapy with Interleukin 2 and Lymphokine Activated Killer Cells",1989,"Cancer Research","49","1",,"235","240",,60,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024492341&partnerID=40&md5=022fcccee981edfe7cf0e2bc4f85f610",Article,Scopus,2-s2.0-0024492341
"Gobmb, H.M., Ratain, M.J., Fefer, A., Thompson, J., Golde, D.W., Ozer, H., Portbck, C., Silber, R., Rappeport, J., Bonnem, E., Spiegel, R., Tensen, L., Burke, J.S., Vardiman, J.W.","Randomized study of the duration of treatment with interferon Alfa-2B in patients with hairy cell leukemia",1988,"Journal of the National Cancer Institute","80","5",,"369","373",,56,10.1093/jnci/80.5.369,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023936183&doi=10.1093%2fjnci%2f80.5.369&partnerID=40&md5=303656338ee735fab34995118f7111e2",Article,Scopus,2-s2.0-0023936183
"Thompson, J.A., Lee, D.J., Lindgren, C.G., Benz, L.A., Collins, C., Levitt, D., Fefer, A.","Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation",1988,"Journal of Clinical Oncology","6","4",,"669","678",,124,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023926926&partnerID=40&md5=c0562b7f4249b28bc751f8fd840a9066",Article,Scopus,2-s2.0-0023926926
"Golomb, H.M., Fefer, A., Golde, D.W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Ratain, M.J., Thompson, J., Bonnem, E., Spiegel, R., Tensen, L., Burke, J.S., Vardiman, J.W.","Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b",1988,"Seminars in Oncology","15","5 SUPPL. 5",,"7","9",,40,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024208812&partnerID=40&md5=c1162c945083c95d986b4fca26d05d3c",Article,Scopus,2-s2.0-0024208812
"Thompson, J.A., Fefer, A.","The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study",1987,"Investigational New Drugs","5","4 Supplement",,"S5","S8",,6,10.1007/BF00207257,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023280246&doi=10.1007%2fBF00207257&partnerID=40&md5=e71db5a374e953d21d09ec07c7edc180",Article,Scopus,2-s2.0-0023280246
"Thompson, J.A., Rubin, E., Fefer, A.","The treatment of hairy cell leukemia with α2b-interferon: Experience with 27 patients treated more than one year",1987,"Leukemia","1","4",,"328","330",,3,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023568316&partnerID=40&md5=37aaf630d8a60568e02a3724bfb2f0d2",Article,Scopus,2-s2.0-0023568316
"Thompson, J.A., Shields, A.F., Porter, B.A., Olson, D.O., Rubin, E., Kidd, P., Fefer, A.","Magnetic resonance imaging of bone marrow in hairy cell leukemia: Correlation with clinical response to α-interferon",1987,"Leukemia","1","4",,"315","316",,11,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023580068&partnerID=40&md5=18201a772def78d65314e56ff87e803e",Article,Scopus,2-s2.0-0023580068
"Cooper, M.R., Fefer, A., Thompson, J., Case Jr., D.C., Kempf, R., Sacher, R., Neefe, J., Bickers, J., Scarffe, J.H., Spiegel, R.J., Bonnem, E.M.","Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial",1987,"Investigational New Drugs","5","4 Supplement",,"S41","S46",,4,10.1007/BF00207262,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023270394&doi=10.1007%2fBF00207262&partnerID=40&md5=69c821dbf404376ce733053a905b5287",Article,Scopus,2-s2.0-0023270394
"Klarnet, J.P., Matis, L.A., Kern, D.E., Mizuno, M.T., Peace, D.J., Thompson, J.A., Greenberg, P.D., Cheever, M.A.","Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory",1987,"Journal of Immunology","138","11",,"4012","4017",,48,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023191788&partnerID=40&md5=812df05c69efc3baf916b28b1d3ef3cd",Article,Scopus,2-s2.0-0023191788
"Thompson, J.A., Cox, W.W., Lindgren, C.G., Collins, C., Neraas, K.A., Bonnem, E.M., Fefer, A.","Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects",1987,"Cancer Immunology Immunotherapy","25","1",,"47","53",,40,10.1007/BF00199300,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023236561&doi=10.1007%2fBF00199300&partnerID=40&md5=6a40e4747d8538513501bb1edded6331",Article,Scopus,2-s2.0-0023236561
"Thompson, J.A., Fefer, A.","Interferon in the treatment of hairy cell leukemia",1987,"Cancer","59","3 S",,"605","609",,17,10.1002/1097-0142(19870201)59:3+&lt;605::AID-CNCR2820591305&gt;3.0.CO;2-4,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023157894&doi=10.1002%2f1097-0142%2819870201%2959%3a3%2b%26lt%3b605%3a%3aAID-CNCR2820591305%26gt%3b3.0.CO%3b2-4&partnerID=40&md5=0a43ffafcfa880b0f9b36d402d4b850d",Article,Scopus,2-s2.0-0023157894
"Thompson, J.A., Cox, W., Lindgren, C.G., Collins, C., Neraas, K.A., Fefer, A.","Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase i trial",1987,"Cancer Research","47","15",,"4202","4207",,70,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023203708&partnerID=40&md5=18a41d5ffdb58b1ce89394d660ec77d7",Article,Scopus,2-s2.0-0023203708
"Golomb, H.M., Fefer, A., Golde, D.W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Ratain, M.J., Thompson, J., Bonnem, E.M., Spiegel, R.J., Tensen, L., Burke, J.S., Vardiman, J.W.","Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia",1987,"Seminars in Oncology","14","2 SUPPL. 2",,"13","17",,54,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023194910&partnerID=40&md5=47a3b21b47f1600908c9c551b16e2950",Article,Scopus,2-s2.0-0023194910
"Thompson, J.A., Peace, D.J., Klarnet, J.P., Kern, D.E., Greenberg, P.D., Cheever, M.A.","Eradication of disseminated murine leukemia by treatment with high-dose interleukin-2",1986,"Journal of Immunology","137","11",,"3675","3680",,96,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022966674&partnerID=40&md5=a0d05b019f8a15187c0ac6b874274308",Article,Scopus,2-s2.0-0022966674
"Cheever, M.A., Thompson, J.A., Peace, D.J., Greenberg, P.D.","Potential Uses of Interleukin 2 in Cancer Therapy",1986,"Immunobiology","172","3-5",,"365","382",,21,10.1016/S0171-2985(86)80118-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022493814&doi=10.1016%2fS0171-2985%2886%2980118-8&partnerID=40&md5=538eb08443da7ab058772f4cdaf72670",Article,Scopus,2-s2.0-0022493814
"Thompson, J.A., Fefer, A., Bonnem, E.","Recombinant alpha2 interferon for the treatment of hairy cell leukemia",1985,"Proceedings of the American Association for Cancer Research","VOL. 26",,,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021823967&partnerID=40&md5=9bdc6d0aa6aee1f8e2648386e316f5b4",Article,Scopus,2-s2.0-0021823967
"Cheever, M.A., Thompson, J.A., Kern, D.E., Greenberg, P.D.","Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth",1985,"Journal of Immunology","134","6",,"3895","3900",,72,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021814332&partnerID=40&md5=c7ac94d1ba5498429662af1926916e0e",Article,Scopus,2-s2.0-0021814332
"Thompson, J.A., Cheever, M.A., Kern, D.E., Greenberg, P.D.","Generation of lymphokine-activated killer (LAK) activity in vivo with recombinant interleukin 2",1985,"Proceedings of the American Association for Cancer Research","VOL. 26",,,"1254","",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021807533&partnerID=40&md5=f1f499363976576bd0efee9bb81daa76",Article,Scopus,2-s2.0-0021807533
"Thompson, J.A., Brady, J., Kidd, P., Fefer, A.","Recombinant alpha-2 interferon in the treatment of hairy cell leukemia",1985,"Cancer Treatment Reports","69","7-8",,"791","793",,40,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021948216&partnerID=40&md5=10419a36875dffc1266a858dd0101d76",Article,Scopus,2-s2.0-0021948216
"Cheever, M.A., Greenberg, P.D., Irle, C., Thompson, J.A., Urdal, D.L., Mochizuki, D.Y., Henney, C.S., Gillis, S.","Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo",1984,"Journal of Immunology","132","5",,"2259","2265",,84,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021321863&partnerID=40&md5=a23d766f2e6236d78a5821d5f9688a44",Article,Scopus,2-s2.0-0021321863
"Cheever, M.A., Thompson, J.A., Kern, D.E., Greenberg, P.D.","Interleukin-2 Administered In Vivo induces the growth and augments the function of cultured T cells in vivo",1984,"Journal of Biological Response Modifiers","3","5",,"462","467",,8,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021189653&partnerID=40&md5=36cefb48042466c8ac3be85893e4ff21",Article,Scopus,2-s2.0-0021189653
